The Leader in Detecting Ocular Biomarkers for Diseases of the Eye, Heart, and Brain
Alzheimer’s Disease Trial
Amydis is developing an eye test that can label and detect amyloid in the retina. This test could help doctors diagnose and monitor AD, and potentially catch the disease early by a simple, low-cost eye scan.
With the help of Amydis’ non-invasive eye test, early diagnosis of CAA may be possible, enabling the opportunity for improved patient care by detecting diseases earlier when they can be most effectively treated.